Tengjun Biotechnology Corp Net Income
| TJBHDelisted Stock | USD 2.00 0.00 0.00% |
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tengjun Biotechnology, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We have analyzed zero technical drivers for Tengjun Biotechnology Corp, which can be compared to its competition.
Tengjun Biotechnology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Tengjun Biotechnology's valuation are provided below:Tengjun Biotechnology Corp does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Tengjun |
Search Suggestions
| T | ATT Inc | Company |
| TVC | Tennessee Valley Authority | Company |
| TDF | Templeton Dragon Closed | Fund |
| TAN | Invesco Solar ETF | ETF |
| TNX | Cboe Interest Rate | Index |
| THC | THC | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Tengjun Biotechnology Corp reported net income of (747,525). This is 100.07% lower than that of the Consumer Defensive sector and 99.24% lower than that of the Packaged Foods industry. The net income for all United States stocks is 100.13% higher than that of the company.
Tengjun Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tengjun Biotechnology's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Tengjun Biotechnology could also be used in its relative valuation, which is a method of valuing Tengjun Biotechnology by comparing valuation metrics of similar companies.Tengjun Biotechnology is currently under evaluation in net income category among its peers.
Tengjun Fundamentals
| Return On Equity | 2.01 | |||
| Return On Asset | 0.34 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 385.53 M | |||
| Shares Outstanding | 96.31 M | |||
| Shares Owned By Insiders | 53.02 % | |||
| Price To Book | 50.08 X | |||
| Price To Sales | 4.19 X | |||
| EBITDA | (424.11 K) | |||
| Net Income | (747.52 K) | |||
| Cash And Equivalents | 6.76 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 301.43 K | |||
| Current Ratio | 0.70 X | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | (561.3 K) | |||
| Earnings Per Share | 0.09 X | |||
| Number Of Employees | 19 | |||
| Beta | 2.53 | |||
| Market Capitalization | 595.19 M | |||
| Total Asset | 14.03 M | |||
| Net Asset | 14.03 M |
About Tengjun Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tengjun Biotechnology Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tengjun Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tengjun Biotechnology Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Tengjun Biotechnology information on this page should be used as a complementary analysis to other Tengjun Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Tengjun OTC Stock
If you are still planning to invest in Tengjun Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tengjun Biotechnology's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |